The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Luncheon Seminar

LS1-4

New Treatment Strategy for Relapse and Refractory Multiple Myeloma

Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.4 (Osaka International Convention Center, 12F 1202)

Chair: Takaaki Chou (Niigata Cancer Center Hospital Hematology/Oncology)

Sponsor: Takeda Pharmaceutical Company Limited

[LS1-4] New Treatment Strategy for Relapse and Refractory Multiple Myeloma

Paul G. Richardson (Harvard Medical School/Dana-Farber Cancer Institute, Boston, MA, USA)